Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
JB received educational grant funding from Bayer
As GLP-1 receptor agonists such as semaglutide, liraglutide, and exenatide become more widely used in treating diabetes and obesity, the demand for accurate analytical characterization continues to grow
This marks the first pharmacologic intervention for overweight or obesity thats been shown in a rigorous fashion to reduce the risk of cardiovascular events. Dr
Abstract Heart Failure with Preserved Ejection Fraction (HFpEF) represents a significant challenge in modern cardiovascular medicine, characterized by diastolic dysfunction and a chronic pro-inflammatory milieu
Control of Appetite and Energy Balance by Estrogens
US$ 25.05
US$ 24.09
US$ 22.80
US$ 22.32
US$ 21.89
US$ 29.83
US$ 21.00
US$ 28.86
US$ 27.01
US$ 21.71
